Literature DB >> 32172817

Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill.

Carlos L Manrique-Caballero1, Sadudee Peerapornratana2, Cassandra Formeck3, Gaspar Del Rio-Pertuz1, Hernando Gomez Danies1, John A Kellum4.   

Abstract

Hemolytic uremic syndrome is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. Disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome have a similar clinical presentation. Diagnostic needs to be prompt to decrease mortality, because identifying the different disorders can help to tailor specific, effective therapies. However, diagnosis is challenging and morbidity and mortality remain high, especially in the critically ill population. Development of clinical prediction scores and rapid diagnostic tests for hemolytic uremic syndrome based on mechanistic knowledge are needed to facilitate early diagnosis and assign timely specific treatments to patients with hemolytic uremic syndrome variants.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical HUS; Complement-mediated HUS; Critically ill; Microangiopathy

Mesh:

Substances:

Year:  2020        PMID: 32172817     DOI: 10.1016/j.ccc.2019.11.004

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  5 in total

1.  Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study.

Authors:  Brandon M Henry; György Sinkovits; Ivan Szergyuk; Maria Helena Santos de Oliveira; Giuseppe Lippi; Justin L Benoit; Emmanuel J Favaloro; Naomi Pode-Shakked; Stefanie W Benoit; David S Cooper; Veronika Müller; Zsolt Iványi; János Gál; Marienn Réti; László Gopcsa; Péter Reményi; Beáta Szathmáry; Botond Lakatos; János Szlávik; Ilona Bobek; Zita Z Prohászka; Zsolt Förhécz; Dorottya Csuka; Lisa Hurler; Erika Kajdácsi; László Cervenak; Blanka Mező; Petra Kiszel; Tamás Masszi; István Vályi-Nagy; Zoltán Prohászka
Journal:  Front Med (Lausanne)       Date:  2022-04-29

2.  Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.

Authors:  Brandon Michael Henry; Ivan Szergyuk; Maria Helena Santos de Oliveira; Giuseppe Lippi; Justin L Benoit; Jens Vikse; Stefanie W Benoit
Journal:  J Med Virol       Date:  2021-05-19       Impact factor: 20.693

3.  Postoperative Atypical Hemolytic Uremic Syndrome in a 67-Year-Old Woman Associated with Hemolytic Anemia, Thrombocytopenia, and Acute Renal Failure.

Authors:  Arnab Chowdhury; Megan P Griffith; Eric Busse; Ahmed Khurshid Pasha
Journal:  Am J Case Rep       Date:  2020-12-08

Review 4.  COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?

Authors:  Ritwick Mondal; Durjoy Lahiri; Shramana Deb; Deebya Bandyopadhyay; Gourav Shome; Sukanya Sarkar; Sudeb R Paria; Tirthankar Guha Thakurta; Pratibha Singla; Subhash C Biswas
Journal:  J Thromb Thrombolysis       Date:  2020-10       Impact factor: 5.221

5.  Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.

Authors:  Cynthia Magro; J Justin Mulvey; David Berlin; Gerard Nuovo; Steven Salvatore; Joanna Harp; Amelia Baxter-Stoltzfus; Jeffrey Laurence
Journal:  Transl Res       Date:  2020-04-15       Impact factor: 7.012

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.